Findings
========

Binding of fH on the borrelial cell surface is critical for resistance to complement-mediated killing by inhibiting the formation of the terminal complement complex \[[@B1],[@B2]\]. Human fH binding has been reported and its association with the pathogenic nature of *Borrelia*species was predicted earlier \[[@B1],[@B3],[@B4]\]. Complement resistant strains (e.g. *B. afzelii*and *B. hermsii*) survive successfully in body compartments where complement concentration is high, whereas it is proposed that *B. garinii*strains do not bind fH on their surface and thus are prone to complement-mediated killing; therefore, they would be able to invade the nervous system where complement concentration is low \[[@B5]\]. However, it has been reported that some OspA serotypes of *B. garinii*can infect and disseminate through the skin \[[@B6]\], and resist human complement mediated killing \[[@B7]\].

The nature of human and animal fH binding ability to *Borrelia*is complex. To date, the majority of studies have focused on human fHBPs of *B. burgdorferi*s.s., *B. afzelii*and *B. hermsii*, using purified fH or recombinant proteins \[[@B3],[@B8]-[@B10]\]. In contrast, here we have analyzed a wider panel of *Borrelia*species, as well as human and different animal sera as source of native fH. We also present how the reservoir competence for *Borrelia*parallels their fH binding ability in different animal species, identifying known as well as not yet described putative fHBPs.

Materials and methods
=====================

First, the reactivity of sheep anti-human fH polyclonal antibody to fH from human and different animal species was assessed (Figure [1](#F1){ref-type="fig"}). Human and animal (mouse, rat, guinea pig, cattle, horse, dog and cat) serum samples, free of antibodies against *B. burgdorferi*, were purchased (Sigma-Aldrich), albumin depleted \[[@B11]\]., fractionated by non-reducing SDS-PAGE (10 μg/well/animal species) and transferred to nitrocellulose membranes. Purified human fH served as a positive control. Membranes were blocked overnight at 4°C in SuperBlock buffer (Pierce, Rockford, IL, USA) and then incubated for 2 hours (37°C with shaking) with sheep anti-human fH polyclonal antibody (Abcam, Cambridge, UK) diluted 1:1,500 in TTBS buffer \[10 mM Tris/HCl (pH 8.3), 0.05% Tween-20 and 150 mM NaCl\] with 1% skim milk. Membranes were washed 3 times with TTBS, incubated with rabbit anti-sheep HRPO antibody (Abcam) diluted to 1:400,000 in TTBS with 1% skim milk for 1 hour (37°C with shaking) and then washed 3 times as above. The reaction was developed by chemiluminescence with SuperSignal West Dura substrate (Pierce).

![**Binding ability of anti-factor H antibody to human and animal fH**. Non-reducing one-dimensional immunoblot of albumin depleted human and animal sera against sheep anti-human fH polyclonal antibody. Purified human fH was used as a positive control.](1756-0500-2-134-1){#F1}

Subsequently, affinity ligand binding immunoblot (ALBI) assays were performed to detect fHBPs of Lyme disease and relapsing fever borreliae (Table [1](#T1){ref-type="table"}). Borrelial strains were grown in BSK-II medium at 33°C, harvested, washed 5 times with PBS supplemented with 5 mM MgCL~2~and then resuspended in ultra pure water containing 1% trifluoroacetic acid (Sigma-Aldrich), 1% of nuclease mix and 1% of a protease inhibitor cocktail (GE Healthcare). Cells were sonicated and total protein concentration was measured (Bradford). Proteins were fractionated by non reducing SDS-PAGE, immunoblotted, and the membranes were cut in 3 mm strips, which were incubated 2 hours either with 1 ml of purified human fH (1,500 μg/ml) as a positive control or human and animal sera (1:4 dilution). fH bound to borrelial proteins was detected with sheep anti-human fH antibody and rabbit anti-sheep HRPO conjugate, as indicated above. Binding was detected by chemiluminescence.

###### 

fH binding proteins, binding strength, calculated molecular mass and isoelectric points estimated in 2-DE.

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  ***Borrelia*species (strain)**   **OspA Serotype**   **MW of fHBP**      **Estimated pI^*a*^**   **Human and animal fH binding affinity**                                         
  -------------------------------- ------------------- ------------------- ----------------------- ------------------------------------------ ------ ----- ----- ------ ----- ----- -----
  *B. burgdorferi*s.s. (SKT2)      1                   **\~26 kDa**^*c*^   8.0-8.1                 +++^*d*^                                   +++    \-    \-    \-     \-    \-    \-

                                                                                                                                                                                    

  *B. afzelii*(SKT4)               2                   **\~15 kDa**        4.0-5.2                 \-                                         +++    \-    \-    \-     \-    +++   ++

                                                       **\~26 kDa**        6.8-7.1                 +++                                        ++     \-    \-    \-     \-    \-    \-

                                                                                                                                                                                    

  *B. garinii*(Rio2)               3                   \-                  \-                      \-                                         \-     \-    \-    \-     \-    \-    \-

                                                                                                                                                                                    

  *B. garinii*(PBi)                4                   **\~19 kDa**        6.0-7.0                 +++                                        \-     \-    \-    \-     \-    \-    \-

                                                       **\~28 kDa**        5.0-5.3                 \-                                         +++    \-    \-    \-     \-    \-    \-

                                                                                                                                                                                    

  *B. garinii*(G117)               5                   \~26 kDa            5.6-6.2                 \-^*e*^                                    ++     \-    \-    \-     \-    \-    \-

                                                                                                                                                                                    

  *B. garinii*(SKT3)               6                   \-                  \-                      \-                                         \-     \-    \-    \-     \-    \-    \-

                                                                                                                                                                                    

  *B. garinii*(T25)                7                   \~17 kDa            5.0-5.5                 ++                                         \-     \-    \-    \-     \-    \-    \-

                                                                                                                                                                                    

  *B. garinii*(CL1)                8                   \-                  \-                      \-                                         \-     \-    \-    \-     \-    \-    \-

                                                                                                                                                                                    

  *B. valaisiana*(VS116)           NA^*f*^             \~17 kDa            4.2-5.0                 +++                                        \-     \-    \-    \-     \-    +++   \-

                                                                                                                                                                                    

  *B. andersonii*(21123)           NA                  \~15 kDa            5.5-6.1                 \+                                         \-     \-    \-    \-     \-    \-    \-

                                                       \~17 kDa            8.0-8.8                 \+                                         \-     \-    \-    \-     \-    \+    \-

                                                       \~23 kDa            6.1-6.6                 \+                                         ++     \-    \-    \-     \-    \-    \-

                                                       \~26 kDa            8.0-8.3                 \-                                         ++     \-    \-    \-     \-    \-    \-

                                                                                                                                                                                    

  *B. lusitaniae*(Poti B2)         NA                  \-                  \-                      \-                                         \-     \-    \-    \-     \-    \-    \-

                                                                                                                                                                                    

  *B. bissettiii*(DN127)           NA                  \~25 kDa            8.0-8.5                 \+                                         \-     \-    \-    \-     \-    \-    \-

                                                       \~28 kDa            5.0-5.5                 \-                                         +++    \-    \-    \-     \-    \-    \-

                                                       \~40 kDa            6.9-7.8                 \-                                         \+     \-    \-    \-     \-    \-    \-

                                                                                                                                                                                    

  *B. japonica*(HO14)              NA                  \~15 kDa            4.8-5.2                 \-                                         +++    ++    \-    \-     \-    \-    \-

                                                       **\~19 kDa**        4.5-5.0                 \-                                         \-     ++    \-    \-     \-    \-    \-

                                                       **\~22 kDa**        6.0-6.8                 \+                                         \-     \-    \-    \-     \-    ++    ++

                                                       \~24 kDa            4.5-4.9                 \-                                         \-     ++    \-    \-     \-    \-    \-

                                                       \~26 kDa            7.9-8.3                 \-                                         +++    \-    \-    \-     \-    \-    \-

                                                                                                                                                                                    

  *B. hermsii*(HS1)                NA                  **\~20 kDa**        8.0-8.3                 +++                                        +++    +++   +++   \-     \-    \-    \-

                                                                                                                                                                                    

  *B. parkeri*(M3001)              NA                  \~23 kDa            8.0-8.5                 ++                                         \-     \-    \-    \-     \-    \-    \-

                                                                                                                                                                                    

  *B. anserina*(ES-1)              NA                  \-                  \-                      \-                                         \-     \-    \-    \-     \-    \-    \-

                                                                                                                                                                                    

  *B. coriaceae*(Co53)             NA                  \~40 kDa\           7.0-8.0\                \-\                                        +++\   \-\   \-\   +++\   \-\   \-\   \-\
                                                       \~**58 kDa**        5.5-5.7                 -                                          +++    ++    -     +++    -     -     -
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

^*a*^pI: isoelectric point; ^*b*^H: human; M: mouse; R: rat; G: guinea pig; C: cattle; Ho: horse; D: dog; Ca: cat; ^*c*^boldface indicate those proteins identified by the mass spectrophotometry and related analysis in this study;^*d*^fH binding strength. +++: high; ++: medium; +: weak; -: negative; ^*e*^This protein was positive when purified human fH was used; ^*f*^NA: not applicable;

To isolate and identify the borrelial proteins showing human/animal fH binding ability, 2-D electrophoresis (2-DE) coupled with MALDI-TOF-TOF was employed. For that, borrelial proteins were cleaned (Bio-Rad Laboratories S.A., Barcelona, Spain) and solubilized in Destreak solution (GE Healthcare, Madrid, Spain). Protein solutions (100 μg) were loaded by rehydration on 7 cm IPG strips (pH 3-11NL or pH 4-7; GE Healthcare), and were focused for 9,142 Vhr using the IPGphor system (GE Healthcare). Strips were equilibrated and subjected to SDS-PAGE on duplicated 15% polyacrylamide gels. One gel was stained with the Silver Stain Plus Kit (Bio-Rad), and the second was subjected to ALBI assay as described above, to ascertain fHBPs. The protein spots of interest were excised from 2-DE gels and digested \[[@B12]\] (Proteineer, Bruker-Daltonics). Digested aliquots were mixed with α-cyano-4-hydroxycinnamic acid in 33% aqueous acetonitrile and 0.25% trifluoroacetic acid. This mixture was deposited onto a 600 μm AnchorChip prestructured MALDI probe (Bruker-Daltonics) and allowed to dry. MALDI-MS data were obtained in an automated analysis loop (Ultraflex, Bruker-Daltonics) equipped with a LIFT-MS/MS device. Spectra were acquired in the positive-ion mode at 50 Hz laser frequency, and 100 to 1000 individual spectra were averaged. Automated analysis of mass data was performed (FlexAnalysis software; Bruker-Daltonics). MALDI-MS and MALDI-MS/MS data were combined (BioTools, Bruker-Daltonics) to search a non-redundant protein database (NCBInr) using Mascot software (Matrix Science). When Mascot search failed to assign a peptide match with *Borrelia*proteins, manual *de novo*sequencing \[[@B13]\] was attempted based on MALDI-MS/MS spectra.

As coiled-coil elements were demonstrated to be involved in the presentation of the fH binding sites \[[@B14],[@B15]\]., putative coiled-coil formation analysis for novel sequences was performed by using PepCoil software \[[@B16]\]<http://bioweb.pasteur.fr/seqanal/interfaces/pepcoil.html>. Lipoprotein signal peptide analysis was done following the description of Setubal *et al*. \[[@B17]\].

Results
=======

A wide repertoire of human fHBP was detected in Borrelia species
----------------------------------------------------------------

Both *B. afzelii*and *B. burgdorferi*s.s. \~26 kDa proteins bound human fH (Figure [2](#F2){ref-type="fig"}, panels A and B, lanes 1 and 2, respectively). A \~19 kDa protein of *B. garinii*serotype 4 and a \~17 kDa protein of *B. garinii*serotype 7 showed human fH binding ability (Figure [2](#F2){ref-type="fig"}, panels A and B, lanes 4 and 7, respectively; Figure [3](#F3){ref-type="fig"}), while other *B. garinii*serotypes (3, 6, and 8) did not express any human fHBP (Figure [2](#F2){ref-type="fig"}, panels A and B, lanes 3, 6 and 8, respectively). Also, a \~26 kDa fHBPs was observed in *B. garinii*serotype 5 when using purified human fH (Figure [2](#F2){ref-type="fig"}, Panel A, lane 5), although the corresponding band when using human serum (Figure [2](#F2){ref-type="fig"}, Panel B, lane 5) was not observed, probably due to the lesser amount of fH present in human serum compared to the amount of purified fH used in the experiment. *B. valaisiana, B. andersonii, B. bissettii*and *B. japonica*also expressed human fHBPs (Figure [2](#F2){ref-type="fig"}, panels A and B, lanes 9, 10, 12 and 13, respectively), although *B. bissettii*binding was weaker when using human serum than purified human factor H, again probably due to the lesser amount of fH present in human serum. Conversely, *B. lusitaniae*did not show any human fHBP in any of the assays (Figure [2](#F2){ref-type="fig"}, panels A and B, lane 11). *B. parkeri*expressed a \~23 kDa human fHBP in our study (Table [1](#T1){ref-type="table"}; Figure [2](#F2){ref-type="fig"}, panels A and B, lane 15). A \~20 kDa human fH putative ligand of *B. hermsii*was also observed in our study (Table [1](#T1){ref-type="table"}; Figure [2](#F2){ref-type="fig"}, panels A and B, lane 14). Consistent with earlier report \[[@B3]\], in the case of *B. anserina*, the causative agent of avian borreliosis, and *B. coriaceae*, the causative agent of epizootic bovine abortion, no human fHBPs were observed.

![**Affinity ligand binding (ALBI) assays**. Non-reducing one-dimensional immunoblot of whole cell sonicates of different *Borrelia*species against purified human fH (Panel A), human serum (Panel B), and mouse serum (Panel C).](1756-0500-2-134-2){#F2}

![**Example of 2D ALBI assay**. Two-dimensional (pH 3-11NL) immunoblot of a whole cell sonicate of *B. garinii*serotype 4 (strain PBi) against human serum, showing a reactive protein of \~19 kDa.](1756-0500-2-134-3){#F3}

Animal fHBPs were also observed in different Borrelia species
-------------------------------------------------------------

Some of the murine fH putative ligands that showed no affinity to human fH in the study were \~15 kDa protein of *B. afzelii*, \~28 kDa protein of *B. garinii*serotype 4, \~28 and \~40 kDa proteins of *B. bissettii*, \~15 and \~26 kDa proteins of *B. japonica*, and \~40 and \~58 kDa proteins of *B. coriaceae*(Table [1](#T1){ref-type="table"}; Figure [2](#F2){ref-type="fig"}, panel C, lanes 1, 4, 12, 13 and 17, respectively).

Amongst Lyme disease *Borreliae*, only *B. japonica*\~15 kDa, \~19 kDa and \~24 kDa proteins showed rat fH binding (Table [1](#T1){ref-type="table"}), while no affinity for guinea pig fH was observed. However, *B. hermsii*\~20 kDa protein showed affinity for both rat and guinea pig fH (Table [1](#T1){ref-type="table"}). As with mouse fH, *B. coriaceae*\~58 kDa protein showed affinity for rat but not for guinea pig fH (Table [1](#T1){ref-type="table"}). As expected, none of the *B. anserina*proteins showed affinity for rodent fH.

Four Lyme disease- (*B. afzelii, B. valaisiana, B. andersonii*and *B. japonica*) and none of the relapsing fever *Borrelia*expressed canine fH binding proteins (Table [1](#T1){ref-type="table"}). The feline fH binding pattern in the array of *Borrelia*studied herein was similar to that of canine fH, except in VS116 (*B. valaisiana*) and 21123 (*B. andersonii*) strains, which were negative.

Finally, none of the *Borrelia*species tested, except *B. coriaceae*(\~40 and \~58 kDa proteins), bound bovine fH (Table [1](#T1){ref-type="table"}). Likewise, none of the *Borrelia*species tested possessed fHBPs that bind horse fH.

Identification of human and animal fHBPs
----------------------------------------

From the ALBI assays, we were able to identify some human fHBPs, not yet described as part of the complement evasion system of *Borrelia*. Although Mascot software failed to find any significant protein hit for the \~19 kDa protein of *B. garinii*serotype 4 (Table [1](#T1){ref-type="table"}, Figure [3](#F3){ref-type="fig"}), manual *de novo*sequencing generated the peptide sequence SNEKLEEDEENEAQQVNSLQNR (Figure [4](#F4){ref-type="fig"}). The short input BLAST search showed a complete sequence homology with a hypothetical protein of *B. garinii*PBi (Genbank [AAU07257](AAU07257)). Unfortunately, neither information regarding the function and topology of this hypothetical protein was available in the protein databases nor proofs of binding were provided to exclude the probability of a contamination, although *in silico*analysis indicated that there was a high probability of two coiled-coil formations near the C-terminus (120 to 147 and 118 to 152 residues with a probability of 1.00). Although coiled-coil motifs are not specific of fHBPs, their presence has been described to be required for the formation of the fH binding site \[[@B14]\], therefore supporting the role of this novel protein in human fH binding \[[@B14],[@B15]\].

![**MALDI-TOF based identification and *de-novo*sequencing**. (Top) MALDI-MS spectrum from the \~19 kDa protein of *B. garinii*ST4 (strain PBi). Relevant mass signals employed for database searching have been labeled and known trypsin and keratin peptide signals have been marked with a black triangle. The precursor ion selected for subsequent MS/MS measurement is indicated by an arrow. (Bottom) MALDI-MS/MS spectrum from the above precursor ion at m/z = 2603.19. Ions ascribed to the main fragmentation series, *y*(C-terminal series) and *b*(N-terminal series) are labeled, and C-terminal fragment ions produced by the loss of ammonia (-17 amu) are indicated by an asterisk (\*). The amino acid sequence obtained by manual *de novo*sequencing is displayed showing assignment of *y*and *b*fragment ions. The letters K and L are used to indicate ambiguous ascription to glutamine/lysine and isoleucine/leucine pairs, respectively.](1756-0500-2-134-4){#F4}

*B. japonica*\~22 kDa human fHBP (Table [1](#T1){ref-type="table"}) was identified as OspE-related lipoprotein (GenBank-accession [AAC62921](AAC62921)), while \~26 kDa human fH binding proteins of *B. burgdorferi*s.s. and *B. afzelii*(Table [1](#T1){ref-type="table"}) were identifed as CspA (*cspA*gene, BBA68) and BaCRASP-1 (ortholog of CspA; *mmsa*71 gene) respectively.

The \~15 kDa murine fH binding *B. afzelii*protein (Table [1](#T1){ref-type="table"}) was identified as an outer membrane protein \[GenBank-accession [YP_853823](YP_853823)\], whilst rat fH binding \~19 kDa protein of *B. japonica*(Table [1](#T1){ref-type="table"}) was identified as OspE-related lipoprotein (GenBank-accession [AAC62921](AAC62921)). Both proteins showed acidic pIs (4.0 -- 5.2) in 2-DE in agreement with their theoretical pI (data not shown). The Mascot search for mouse fH-binding \~28 kDa protein of *B. garinii*serotype 4 showed a significant match and pI in agreement with the recently described BgCRASP-1 (likely to be orthologous of CspA; GenBank-accession [CAH10086](CAH10086)).

We identified a \~58 kDa *B. coriaceae*protein (Table [1](#T1){ref-type="table"}) as a member of the bacterial extracellular solute-binding protein (BESBP) family. In fact, this is a probable lipoprotein according to the known features for lipoprotein signal peptides in spirochaetes \[[@B17]\]. For the \~40 kDa bovine fHBP of this species (Table [1](#T1){ref-type="table"}) no confident protein match was found. Manual *de novo*sequencing for \~20 kDa *B. hermsii*protein (Table [1](#T1){ref-type="table"}) using the corresponding MS/MS fragmentation spectra yielded two putative sequences: TLDNLLK (815.9 Da) and YLLVIFLLLSLASCDLFLK (2185.2 Da), which revealed high homology with the earlier characterized FhbA \[[@B18]\] of *B-hermsii*. (GenBank-accession [AAY42861](AAY42861)).

Discussion
==========

Among the putative human fHBPs, we have found a \~19 kDa *B. garinii*serotype 4 protein different (only 12.3% of amino acid sequence similarity) from the earlier reported BgCRASP-1 described in this genospecies \[[@B19]\], as well as from the earlier cited *B. burgdorferi*s.s. or *B. afzelii*fHBPs. It is proposed that the fHBPs of Lyme disease borreliae possess linear sequence elements involved in fH binding \[[@B20]\]. However, a sequence similarity of 15 to 18% between CspA and the rest of Erp related fHBPs (ErpA, ErpC and ErpP) indicates that this may not always be the case. A further detailed study has provided evidence that fH binding is rather dependant on protein conformation \[[@B5]\], and formation of coiled-coil motifs \[[@B10],[@B14]\]. The high probability of coiled-coil formation observed in *in silico*analysis for this putative \~19 kDa human fHBP and its amino acid divergence from other fHBPs strengthens these findings.

*B. garinii*is the most heterogeneous species in terms of plasmid content and OspA serotype \[[@B21],[@B22]\], and these differences could account for different fHBP expression and complement susceptibility. Therefore, it is not at all surprising that some of the *B. garinii*serotypes that bound human fH in this study (OspA serotypes 4 and 7) also resisted complement mediated killing in a previous experiment \[[@B7]\]. Human fH binding by *B. valaisiana*could correspond to its proposed ability to produce erythema migrans \[[@B23]\], and the absence of human fH binding by *B. anserina*and *B. coriaceae*observed in our experiments correlates with the fact that these species do not infect humans.

The host selectivity of different *Borrelia*species correlates with their complement sensitivity, and thus also with their fH binding profile \[[@B7],[@B24],[@B25]\]. We show novel murine fH putative ligands expressed by Lyme disease *Borrelia*and *B. coriaceae*. The murine fH binding ability of *B. bissettii*and *B. japonica*strengthens their survival in rodents \[[@B26],[@B27]\]. Moreover, the putative murine fHBP identified herein in *B. garinii*OspA serotype 4 correlates with the described ability of these strains to survive in mice \[[@B28]\].

We and others have reported that cattle and horses are not suitable hosts for Lyme disease related *Borreliae*\[[@B7],[@B24],[@B29]\], which strongly correlates with the inability of borrelial proteins to bind bovine and equine fH. However, binding of bovine fH only by *B. coriaceae*(\~40 kDa & \~58 kDa proteins) suggests that cattle are a primary host for this *Borrelia*species. We have found a \~58 kDa protein that appears to have a bovine fH binding ability, to be a BESBP that may be an immune evasion tool of *B. coriaceae*in bovine. Like in other fHBPs, the \~58 kDa protein is a putative lipoprotein, as per the requirements described by Setubal *et al*. \[[@B17]\]., which suggest that it is located in the membrane.

The role of carnivores as hosts for *Borrelia*is probably limited. In this study we have noticed canine fHBPs in *B. afzelii*and *B. valaisiana*and, although with weak signals, also in *B. andersoni*and *B. japonica*, that could account for the ability of these genospecies to infect dogs \[[@B30]\]. Feline fHBPs has been detected, as well, in *B. afzelii*and *B. japonica*, although neither good data regarding reservoir competence nor pathogenicity of *Borrelia*in these hosts is available.

In summary, the fH binding strategy employed by *Borrelia*species in different hosts is complex. Novel, putative human and animal fHBPs have been found in this study, which highlights the multiplicity of the immune evading arsenal that *Borrelia*possesses.
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